South Korea OKs First-in-Class Gene Therapy for Osteoarthritis – Genetic Engineering & Biotechnology News
pulse |
South Korea OKs First-in-Class Gene Therapy for Osteoarthritis
Genetic Engineering & Biotechnology News South Korea’s Ministry of Food and Drug Safety said today that it has approved the country’s first gene therapy for osteoarthritis, the lead product candidate of a Maryland-based regenerative medicine company. Invossa-K Inj. was developed by … Korea Approves the World’s First Cell and Gene Therapy for Knee OsteoarthritisPR Newswire (press release) Korea’s first gene therapy Invossa cleared to be sold in Korea …pulse Korea approves first cell gene therapy ‘Invossa’ for degenerative arthritisAsiaOne Korea Biomedical Review –Yonhap News all 7 news articles » |
Weekly Register |
iBio, Inc. (IBIO) Announces US Patent Granted to AzarGen …
StreetInsider.com Get access to the best calls on Wall Street with StreetInsider.com’s Ratings Insider Elite. Get your Free Trial here. AzarGen Biotechnologies (Pty) Ltd … Collaboration Partner Pulls Ibio Inc (NYSEMKT:IBIO) Higher – Stock …StockNewsUnion |
Business Insider |
First gene therapy on the cusp of FDA approval
Pharmacy Today, American Pharmacists Association, pharmacist.com An FDA advisory panel will make the call July 12 to recommend for or against agency approval of the first gene therapy. A favorable decision could see the regulator sanction the treatment by early this fall. Drug manufacturer Novartis and the … FDA panel to focus on safety of Novartis gene therapy drug …Business Insider Novartis’ CAR-T Therapy for Pediatric Leukemia to Face FDA Advisory PanelAJMC.com Managed Markets Network |
BioTechniques.com |
INJECTING NANOPARTICLES INTO IMMUNOTHERAPY
BioTechniques.com This is the delicate balance that makes immunotherapy tricky. “The immune system is always integrating all these signals. It’s never on or off. It’s just always a balance,” says Christopher Jewell, a chemical engineer at the University of Maryland in … |
Science Magazine |
A stem cell transplant helped beat back a young doctor’s cancer. Now, it’s assaulting his body
Science Magazine Stem cells from his brother’s marrow reconstituted his blood cells, including immune system cells, and within a year, Wartman was working full time and running regularly. “I was almost back to my baseline,” he says, as his runs gradually lengthened and … |
Science Magazine |
A stem cell transplant helped beat back a young doctor’s cancer …
Science Magazine Graft-versus-host disease is an often debilitating consequence of a common leukemia cure. |
|
US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology
PR Newswire (press release) AzarGen has recently been featured on CB Insights’ top global synthetic biology start-up companies market map list. AzarGen also recently expanded its collaboration with iBio, Inc. (NYSE MKT: IBIO), a leader in developing plant-based biopharmaceuticals … |